AMANDA ECKERSLEY: Open Payments
NPI 1447802418 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 37 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $352 · 2025 $1,458
Food & beverage: $1,425Education: $33
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $246 |
| Amgen Inc. | 2 | $158 |
| GlaxoSmithKline, LLC. | 7 | $149 |
| Tempus AI, Inc | 2 | $131 |
| ABBVIE INC. | 2 | $129 |
| Janssen Biotech, Inc. | 4 | $104 |
| Incyte Corporation | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Adaptive Biotechnologies Corporation | 1 | $69 |
| TerSera Therapeutics LLC | 2 | $55 |
Products named: DARZALEX, XT CDX, EPKINLY, IMDELLTRA (AMG757), OJJAARA, Jakafi, clonoSEQ, RYBREVANT.
Industry payments across UT — which companies pay providers there.
